广誉远(600771.SH)：半夏泻心汤颗粒获得药品注册证书

Core Viewpoint - Guangyuyuan (600771.SH) announced that its subsidiary, Shanxi Guangyuyuan Traditional Chinese Medicine Co., Ltd., received the drug registration certificate for Banxia Xiexin Decoction Granules from the National Medical Products Administration, enhancing its product portfolio in traditional Chinese medicine [1] Group 1 - The prescription for Banxia Xiexin Decoction Granules is derived from Zhang Zhongjing's "Shanghan Lun" from the Han Dynasty and is included in the first batch of the "Directory of Classic Ancient Formulas" published by the National Administration of Traditional Chinese Medicine [1] - The function and indications of Banxia Xiexin Decoction Granules include balancing cold and heat, dispersing masses, and alleviating fullness without pain, as well as symptoms such as vomiting, intestinal rumbling, and diarrhea [1] - The acquisition of the drug registration certificate for Banxia Xiexin Decoction Granules further enriches the company's range of traditional Chinese medicine products and will synergize with existing core products [1]